Skip to main content

Table 3 Intravenous iron prescribing in pregnancy and association with obstetrician demographics

From: The use of intravenous iron in pregnancy: for whom and when? A survey of Australian and New Zealand obstetricians

  Frequency (n) and percentage (%) IV iron prescribing in pregnancy (n, %)a P-value
Yes No
Time since obtaining FRANZCOG or overseas equivalent (n = 441)
  < 10 years 178 (40.4) 176 (98.9) 2 (1.1) 0.014C*
  ≥ 10 years 263 (59.6) 248 (94.3) 15 (5.7)  
Area of practice (n = 438)
 Australia 384 (87.7) 368 (95.8) 16 (4.2) 0.707F
 New Zealand 54 (12.3) 53 (98.1) 1 (1.9)  
Practice setting (n = 441)
 Metropolitanb 323 (73.2) 310 (96.0) 13 (4.0) 1.000F
 Non-metropolitan 118 (26.8) 113 (95.8) 5 (4.2)  
 Publicc 342 (77.6) 333 (97.4) 9 (2.6) 0.008F**
 Not public 99 (22.4) 90 (90.9) 9 (9.1)  
Births per annum in largest hospital of practice (n = 444)
  < 2500 192 (43.2) 179 (93.2) 13 (6.8) 0.011C***
  > 2500 252 (56.8) 247 (98.0) 5 (2.0)  
  1. Abbreviations: IV intravenous; FRANZCOG Fellowship of Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Superscript: F, Fisher’s Exact; C, Pearson’s Chi-Squared
  2. an = 444
  3. b“Metropolitan” represents clinicians whose practice sites include metropolitan public and/or metropolitan private hospitals; “non-metropolitan” includes clinicians who practice exclusively in non-metropolitan public hospitals, non-metropolitan private hospitals or others
  4. c“Public” represents clinicians whose practice sites include metropolitan public and/or non-metropolitan public hospitals; “not public” includes clinicians who practice exclusively in metropolitan private hospitals, non-metropolitan private hospitals or others